Investigating the Regulation of IRF4 in Adipocytes

Information

  • Research Project
  • 10106625
  • ApplicationId
    10106625
  • Core Project Number
    F32DK124914
  • Full Project Number
    5F32DK124914-02
  • Serial Number
    124914
  • FOA Number
    PA-19-188
  • Sub Project Id
  • Project Start Date
    6/30/2020 - 4 years ago
  • Project End Date
    6/29/2022 - 2 years ago
  • Program Officer Name
    CASTLE, ARTHUR
  • Budget Start Date
    6/30/2021 - 3 years ago
  • Budget End Date
    6/29/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    02
  • Suffix
  • Award Notice Date
    9/17/2021 - 3 years ago

Investigating the Regulation of IRF4 in Adipocytes

Project Summary Adipose tissue is a central player in energy balance and glucose homeostasis, it is able to expand in the face of caloric overload in order to store energy safely, but it can become overloaded and dysfunctional, leading to systemic metabolic compromise in the form of insulin resistance and Type 2 diabetes. Transcription factors such as interferon regulatory factor 4 (IRF4) are key regulators of adipose tissue function, but there is much we still do not know about IRF4 regulation. We performed mass spectrometry for IRF4 binding partners in adipocytes, as well as ChIP-seq to generate a cistrome for IRF4 at the basal state, and found that IRF4 physically interacts with and may be negatively regulated by the closely related protein IRF8. We further found that IRF8 fat specific knockout animals show an opposite phenotype to IRF4 fat specific knockouts, further indicating the inverse roles of these proteins. In this application my objective is to definitively identify and characterize the IRF4:IRF8 interaction and its consequences in adipocytes. To do this I will characterize this physical interaction by studying the metabolic conditions under which IRF4 and IRF8 are likely to interact and assaying the functionality of point mutants that can no longer bind each other. I will further generate a cistrome for IRF8 binding in adipocytes and study how the cistromes of both IRF4 and IRF8 change under different metabolic stressors. Finally, I will investigate the dependence of the IRF8 phenotype on its negative regulation of IRF4 by breeding fat specific double knockout animals and metabolically phenotyping them. By studying the regulation of IRF4 in adipocytes, both by IRF8 and by metabolic stimuli, we can better understand and target pathways that can allow adipocytes to maintain metabolic homeostasis during obesity and thus prevent metabolic disease.

IC Name
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES
  • Activity
    F32
  • Administering IC
    DK
  • Application Type
    5
  • Direct Cost Amount
    66390
  • Indirect Cost Amount
  • Total Cost
    66390
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    847
  • Ed Inst. Type
  • Funding ICs
    NIDDK:66390\
  • Funding Mechanism
    TRAINING, INDIVIDUAL
  • Study Section
    ZDK1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    BETH ISRAEL DEACONESS MEDICAL CENTER
  • Organization Department
  • Organization DUNS
    071723621
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    022155400
  • Organization District
    UNITED STATES